The development of imatinib as a therapeutic agent for chronic myeloid leukemia Michael Deininger, Elisabeth Buchdunger,et al. Blood 2005;105: 2640-2653
Translocations involving anaplastic lymphoma kinase (ALK) Justus Duyster,Ren-Yuan Bai,et al. Oncogene 2001;20:5623-5637
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma Helen Y. Zou, Maria E. Arango, et al. Mol Cancer Ther 2007;6:3314-3322
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.